Stocks
Allogene Therapeutics (ALLO) ROA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | -17.3% | -41.4% | -50.9% | -46.9% | -45.9% | -43.9% | ||
| Changes by years, y/y, % | +3pp | -24pp | -9pp | +4pp | +1pp | +17.6% | |||
Allogene Therapeutics. ROA, %
Allogene Therapeutics. ROA, changes, pp
Allogene Therapeutics (ALLO) ROA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROA, % | ? | -49.7% | -50.3% | -48.2% | -45.9% | -43.9% | -43.9% | |
| Changes by years, y/y, % | +1pp | -7pp | +0pp | +1pp | +6pp | |||
| Changes by quarters, q/q, % | -3pp | -1pp | +2pp | +2pp | +2pp | |||
